Showing results (361-370 of 6,786) with videos related to
Sort By:
Pageof 679
Clinical Therapeutics|May 19, 2009
Etravirine: a second-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) active against NNRTI-resistant strains of HIVDaryl S Schiller, Manal Youssef-BesslerClinical Therapeutics|May 19, 2009
A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholdsGiannapia Affaitati, Alessandra Fabrizio, Antonella Savini, et al.Clinical Therapeutics|May 19, 2009
Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) studyRonald Emkey, Pierre D Delmas, Michael Bolognese, et al.Clinical Therapeutics|May 19, 2009
Pharmacokinetics and bioequivalence evaluation of two formulations of 10-mg amlodipine besylate: an open-label, single-dose, randomized, two-way crossover study in healthy Chinese male volunteersYun Liu, Jingying Jia, Gangyi Liu, et al.Clinical Therapeutics|May 19, 2009
Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjectsSung-Doo Kim, Wonku Kang, Hae Won Lee, et al.Clinical Therapeutics|May 19, 2009
Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care populationDaniel A Ollendorf, David Klingman, Elisabeth Hazard, et al.Clinical Therapeutics|May 19, 2009
Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribingNadia Barozzi, Susan E TettClinical Therapeutics|May 19, 2009
Modified visual analog scale symptom-intensity and overall-bother measures for the assessment of symptoms in studies of pharmacologic stress agentsGale Harding, Karin Coyne, Richard J Barrett, et al.Clinical Therapeutics|October 8, 2009
Anthracycline- and/or taxane-resistant breast cancer: results of a literature review to determine the clinical challenges and current treatment trendsAlvaro Moreno-Aspitia, Edith A PerezClinical Therapeutics|October 8, 2009
Comparison of the efficacy and safety of arformoterol 15 microg twice daily and arformoterol 30 microg once daily in COPD: a single-dose, multicenter, randomized, modified-blind, two-way crossover studyReynold A Panettieri, Neil MacIntyre, Michael Sims, et al.Pageof 679